A Model to Predict the Risk of Keratinocyte Carcinomas
Authors:
- David C. WhitemanDWDavid C. Whiteman
- Bridie S. ThompsonBTBridie S. Thompson
- Rachel E. NealeRNRachel E. Neale
- Catherine M. OlsenCOCatherine M. Olsen
- Penelope M. WebbPWPenelope M. Webb
- Lea M. JackmanLJLea M. Jackman
- Barbara A. RanieriBRBarbara A. Ranieri
- Rebekah A. CiceroRCRebekah A. Cicero
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (6) , 1247-1254
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer ChemopreventionNew England Journal of Medicine, 2015
- Independent Validation of Six Melanoma Risk Prediction ModelsJournal of Investigative Dermatology, 2015
- Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011Journal of the American Academy of Dermatology, 2014
- Good test–retest reproducibility for an instrument to capture self-reported melanoma risk factorsJournal of Clinical Epidemiology, 2012
- Effectiveness of skin cancer screening programmesBritish Journal of Dermatology, 2012
- Cohort profile: The QSkin Sun and Health StudyInternational Journal of Epidemiology, 2012
- A systematic review of worldwide incidence of nonmelanoma skin cancerBritish Journal of Dermatology, 2012
- Prognosis and prognostic research: application and impact of prognostic models in clinical practiceBMJ, 2009
- Skin cancer is among the most costly of all cancers to treat for the Medicare populationJournal of the American Academy of Dermatology, 2003
- Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mLUrology, 1999